...
首页> 外文期刊>Pharmaceutical research >Solubilizing excipients in oral and injectable formulations.
【24h】

Solubilizing excipients in oral and injectable formulations.

机译:口服和注射制剂中的增溶赋形剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A review of commercially available oral and injectable solution formulations reveals that the solubilizing excipients include water-soluble organic solvents (polyethylene glycol 300, polyethylene glycol 400, ethanol, propylene glycol, glycerin, N-methyl-2-pyrrolidone, dimethylacetamide, and dimethylsulfoxide), non-ionic surfactants (Cremophor EL, Cremophor RH 40, Cremophor RH 60, d-alpha-tocopherol polyethylene glycol 1000 succinate, polysorbate 20, polysorbate 80, Solutol HS 15, sorbitan monooleate, poloxamer 407, Labrafil M-1944CS, Labrafil M-2125CS, Labrasol, Gellucire 44/14, Softigen 767, and mono- and di-fatty acid esters of PEG 300, 400, or 1750), water-insoluble lipids (castor oil, corn oil, cottonseed oil, olive oil, peanut oil, peppermint oil, safflower oil, sesame oil, soybean oil, hydrogenated vegetable oils, hydrogenated soybean oil, and medium-chain triglycerides of coconut oil and palm seed oil), organic liquids/semi-solids (beeswax, d-alpha-tocopherol, oleic acid, medium-chain mono- and diglycerides), various cyclodextrins (alpha-cyclodextrin, beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, and sulfobutylether-beta-cyclodextrin), and phospholipids (hydrogenated soy phosphatidylcholine, distearoylphosphatidylglycerol, L-alpha-dimyristoylphosphatidylcholine, L-alpha-dimyristoylphosphatidylglycerol). The chemical techniques to solubilize water-insoluble drugs for oral and injection administration include pH adjustment, cosolvents, complexation, microemulsions, self-emulsifying drug delivery systems, micelles, liposomes, and emulsions.
机译:对可商购的口服和注射液制剂的审查显示,增溶性赋形剂包括水溶性有机溶剂(聚乙二醇300,聚乙二醇400,乙醇,丙二醇,甘油,N-甲基-2-吡咯烷酮,二甲基乙酰胺和二甲基亚砜) ,非离子表面活性剂(Cremophor EL,Cremophor RH 40,Cremophor RH 60,d-α-生育酚聚乙二醇1000琥珀酸酯,聚山梨酸酯20,聚山梨酸酯80,Solutol HS 15,脱水山梨醇单油酸酯,泊洛沙姆407,Labrafil M-1944CS,Labrafil M -2125CS,Labrasol,Gellucire 44/14,Softigen 767以及PEG 300、400或1750的单脂肪酸和二脂肪酸酯,水不溶性脂质(蓖麻油,玉米油,棉籽油,橄榄油,花生油,薄荷油,红花油,芝麻油,大豆油,氢化植物油,氢化大豆油以及椰子油和棕榈籽油的中链甘油三酸酯),有机液体/半固体(蜂蜡,d-α-生育酚) ,油酸,中等链甘油单酯和甘油二酯),各种环糊精(α-环糊精,β-环糊精,羟丙基-β-环糊精和磺基丁基醚-β-环糊精)和磷脂(氢化大豆磷脂酰胆碱,二硬脂酰基磷脂酰甘油,L-α-二豆蔻酰基磷脂酰甘油) α-二肉豆蔻酰基磷脂酰甘油)。增溶用于口服和注射给药的水不溶性药物的化学技术包括pH调节,助溶剂,络合,微乳液,自乳化药物递送系统,胶束,脂质体和乳液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号